SymBio Pharmaceuticals' market value is the price at which a share of SymBio Pharmaceuticals trades on a public exchange. It measures the collective expectations of SymBio Pharmaceuticals Limited investors about its performance. SymBio Pharmaceuticals is trading at 0.64 as of the 8th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 0.64. With this module, you can estimate the performance of a buy and hold strategy of SymBio Pharmaceuticals Limited and determine expected loss or profit from investing in SymBio Pharmaceuticals over a given investment horizon. Check out SymBio Pharmaceuticals Correlation, SymBio Pharmaceuticals Volatility and SymBio Pharmaceuticals Alpha and Beta module to complement your research on SymBio Pharmaceuticals.
Please note, there is a significant difference between SymBio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if SymBio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SymBio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
SymBio Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SymBio Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SymBio Pharmaceuticals.
0.00
12/09/2025
No Change 0.00
0.0
In 30 days
01/08/2026
0.00
If you would invest 0.00 in SymBio Pharmaceuticals on December 9, 2025 and sell it all today you would earn a total of 0.00 from holding SymBio Pharmaceuticals Limited or generate 0.0% return on investment in SymBio Pharmaceuticals over 30 days. SymBio Pharmaceuticals is related to or competes with Goodness Growth, and InnoCan Pharma. SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical d... More
SymBio Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SymBio Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SymBio Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for SymBio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SymBio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use SymBio Pharmaceuticals historical prices to predict the future SymBio Pharmaceuticals' volatility.
SymBio Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13 % return per unit of risk over the last 3 months. SymBio Pharmaceuticals Limited exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SymBio Pharmaceuticals' Variance of 9.84, risk adjusted performance of (0.09), and Coefficient Of Variation of (787.40) to confirm the risk estimate we provide. The entity has a beta of 1.07, which indicates a somewhat significant risk relative to the market. SymBio Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, SymBio Pharmaceuticals is expected to follow. At this point, SymBio Pharmaceuticals has a negative expected return of -0.4%. Please make sure to validate SymBio Pharmaceuticals' information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if SymBio Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
1.00
Perfect predictability
SymBio Pharmaceuticals Limited has perfect predictability. Overlapping area represents the amount of predictability between SymBio Pharmaceuticals time series from 9th of December 2025 to 24th of December 2025 and 24th of December 2025 to 8th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SymBio Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current SymBio Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
1.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
SymBio Pharmaceuticals lagged returns against current returns
Autocorrelation, which is SymBio Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SymBio Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of SymBio Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that SymBio Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
SymBio Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SymBio Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SymBio Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SymBio Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
SymBio Pharmaceuticals Lagged Returns
When evaluating SymBio Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SymBio Pharmaceuticals pink sheet have on its future price. SymBio Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SymBio Pharmaceuticals autocorrelation shows the relationship between SymBio Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in SymBio Pharmaceuticals Limited.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running SymBio Pharmaceuticals' price analysis, check to measure SymBio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SymBio Pharmaceuticals is operating at the current time. Most of SymBio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of SymBio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SymBio Pharmaceuticals' price. Additionally, you may evaluate how the addition of SymBio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.